NATCO Pharma Limited

Rentabilité sur six mois: -28.87%
Rendement en dividendes: 0.7538%

912.55 ₹

0 ₹ 0%
746.85 ₹
1592.6 ₹

paper.min_max_per_year

Calendrier des promotions NATCO Pharma Limited

À propos de l'entreprise NATCO Pharma Limited

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Paramètres de base

ISIN
INE987B01026
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.9395
Дивиденд ао
6
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 4.28 4
P/BV 2.91 6
P/E 12.27 8
Efficacité
Nom Signification Grade
ROA 22.1 7
ROE 25.88 8
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0.7538 1.88
DSI 0.8571 8.57
Croissance moyenne du dividende -2.74 0
Devoir
Nom Signification Grade
Debt/EBITDA 0.1605 10
Debt/Ratio 0.0242 10
Debt/Equity 0.1799 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 110.76 10
Rentabilité Ebitda, % 12.83 2
Rentabilité EPS, % 206.73 10

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 912.55 ₹ 0 ₹ 0 ₹ 0 % 0 % 0 %
common.calendar.number_days.7d 863.45 ₹ 0 ₹ 0 ₹ +5.69 % 0 % 0 %
common.calendar.number_days.30d 879.9 ₹ 0 ₹ 0 ₹ +3.71 % 0 % 0 %
common.calendar.number_days.90d 746.85 ₹ 803 ₹ 934.25 ₹ +22.19 % 0 % 0 %
common.calendar.number_days.180d 1 283 ₹ 746.85 ₹ 1 327.35 ₹ -28.87 % 0 % 0 %
common.calendar.number_days.1y 1 563.75 ₹ 746.85 ₹ 1 592.6 ₹ -41.64 % 0 % 0 %
common.calendar.number_days.3y 615.45 ₹ 522.75 ₹ 1 592.6 ₹ +48.27 % 0 % 0 %
common.calendar.number_days.5y 717.9 ₹ 522.75 ₹ 1 592.6 ₹ +27.11 % 0 % 0 %
common.calendar.number_days.10y 392.55 ₹ 392.55 ₹ 2 608.6 ₹ +232.47 % 0 % 0 %
common.calendar.number_days.ytd 1 256.8 ₹ 746.85 ₹ 1 385.35 ₹ -27.39 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Rajeev Nannapaneni CEO & Vice Chairman N/A 1977 (48 années)
Mr. S. V. V. N. Appa Rao Chief Financial Officer N/A
Dr. Donthineni Linga Rao M.D. President of Technical Affairs & Whole Time Director N/A 1952 (73 année)
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS. MD & Chairman N/A 1945 (80 années)
Mr. Potluri Sivaramakrishna Prasad Executive VP of Corporate Engineering Services & Whole Time Director N/A 1958 (67 années)
Mr. Chekuri Venkat Ramesh C.S. Company Secretary & Compliance Officer 3M
Dr. Pavan Ganapati Bhat Executive VP of Technical Operations & Director N/A 1967 (58 années)
N. Sadasiva Rao Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management N/A
James Rajakumar Vice President of Marketing & Sales - Domestic N/A
Nadella Malleswara Rao VP & Head of Operations

Informations sur l'entreprise

Adresse: India, Hyderabad, Natco House - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.natcopharma.co.in